by PKD Foundation Staff | May 9, 2018 | Research
The announcement of our first FDA-approved treatment for ADPKD is not only a major success for PKD patients, but also for nephrologists who have spent decades caring for their health. We reached out recently to Vicente Torres, M.D., Ph.D., of the Mayo Clinic...
by PKD Foundation Staff | May 8, 2018 | Research
Our very own Dr. David Baron shares his personal background with PKD, his journey joining the Foundation and his thoughts on the exciting news about the new treatment for ADPKD: Little did I know when I was studying the effects of vasopressin and its modulators...
by PKD Foundation Staff | Apr 25, 2018 | ADPKD, Research
In light of our exciting news about tolvaptan receiving FDA approval as the first ADPKD treatment, we reached out to Benjamin Cowley Jr., M.D. to explain how we reached this amazing milestone. Dr. Cowley was on the Independent Data Monitoring Committee for the...
by PKD Foundation Staff | Apr 24, 2018 | ADPKD, PKD Foundation News, Research
Today is a historic day in providing hope to patients with polycystic kidney disease. We are excited to announce that the U.S. Food and Drug Administration (FDA) granted approval of JYNARQUE™ (tolvaptan) to be the first treatment in the United States for adult...
by PKD Foundation Staff | Mar 20, 2018 | Research
Meet Michal Mrug, M.D., Chair of the PKD Foundation Scientific Advisory Panel (SAP). The Scientific Advisory Panel is comprised of 14 of the most prestigious physicians and scientists in the United States investigating the causes of and treatments for PKD. Together,...
by Valen Keefer | Nov 12, 2015 | PKD Will Not Beat Me, Research
On our PKD journey, patients and researchers search for many answers, all with the common goal of discovering a cure. We patients may search to find out why we have this disease, what we can do to lead the healthiest lives, where we can obtain the best care or when we...
